Study reveals new genetic explanation for dilated cardiomyopathy

A potentially life-changing heart condition, dilated cardiomyopathy, can be caused by the cumulative influence of hundreds or thousands of genes and not just by a single “aberrant” genetic variant, as was previously thought, finds a new study led by researchers at UCL (University College London), Imperial College London and the MRC Laboratory of Medical Sciences.

Medtronic to evaluate Affera in ventricular tachycardia

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic has received Food and

October 15, 2024

23andMe rival warns consumer test approach misses 90% of cancer variants

Dive Brief: Direct-to-consumer genetic testing has limited utility for identifying patients at risk of hereditary breast or ovarian cancer, according to a study published in

August 17, 2023

Covid and Medicare payments spark remote patient monitoring boom

Billy Abbott, a retired Army medic, wakes at 6 every morning, steps on the bathroom scale, and uses a cuff to take his blood pressure.

March 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.